Trinity Biotech plc
TRIB
$0.7634
$0.05547.83%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 18.14% | -12.24% | -3.08% | -12.68% | 7.84% |
| Total Depreciation and Amortization | 101.75% | -52.69% | -19.60% | -74.60% | 185.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.51% | 74.58% | -38.23% | 4.24% | -10.34% |
| Change in Net Operating Assets | 158.40% | -79.97% | 5.21% | 988.89% | 106.90% |
| Cash from Operations | 105.25% | -5.59% | -62.51% | 170.86% | 134.99% |
| Capital Expenditure | -95.31% | 15.23% | 44.89% | -47.98% | -124.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.44% | -83.54% | 60.85% | 34.00% | 39.51% |
| Cash from Investing | -0.56% | -103.18% | 2,196.46% | 14.12% | 26.49% |
| Total Debt Issued | -- | -- | -96.97% | -- | -- |
| Total Debt Repaid | 2.28% | 94.63% | -1,676.63% | 12.28% | 98.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 35.05% | 37.18% | -11.90% | 29.86% | 69.10% |
| Cash from Financing | 27.35% | 81.93% | -936.82% | 40.85% | -154.82% |
| Foreign Exchange rate Adjustments | -1,228.57% | -83.72% | 514.29% | 118.44% | -16.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.74% | -179.08% | 515.46% | 78.87% | -825.40% |